This article analyzes the antitrust exposure for reverse-payment settlement agreements between generic and brand-name pharmaceutical companies, by discussing relevant case law as well as FTC and Department of Justice positions.
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.
